Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials

Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma with a poor prognosis. Although these tumors are sensitive to radiotherapy/chemotherapy, the standard treatment for localized MCS is only surgical resection, and there are no established treatment guidelines for patients with advan...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2023-09, Vol.15 (18), p.4581
Hauptverfasser:	Dudzisz-Śledź, Monika, Kondracka, Monika, Rudzińska, Monika, Zając, Agnieszka E, Firlej, Wiktoria, Sulejczak, Dorota, Borkowska, Aneta, Szostakowski, Bartłomiej, Szumera-Ciećkiewicz, Anna, Piątkowski, Jakub, Rutkowski, Piotr, Czarnecka, Anna M
Format:	Artikel
Sprache:	eng
Schlagworte:	AKT protein Antimitotic agents Antineoplastic agents Bcl-2 protein Biopsy Bones Calcification Cancer Cartilage CD99 antigen Chemotherapy Chondrosarcoma Clinical trials Cyclin-dependent kinase Diagnosis Enzyme inhibitors Epigenetic inheritance Epigenetics Ezrin Gender differences Genes Hematology Histopathology Immunotherapy Magnetic resonance imaging Mediation Metastases Metastasis Mineralization Nkx2.2 protein Oncology p53 Protein Pathogenesis Patients Pediatrics Platelet-derived growth factor Protein kinase C Protein kinase inhibitors Protein kinases Radiation therapy Review Sarcoma Sox9 protein Stem cells Tomography Tumor proteins Tumors Zoledronic acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!